Screener
Opko Health OPK Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|
| Proceeds from the sale of property, plant and equipment | 181 | 181 |
| Capital expenditures | (4,837) | (6,477) |
| Proceeds from Labcorp sale | 18,392 | — |
| Net cash (used in) provided by investing activities | 13,736 | 37,694 |
| Cash flows from financing activities: | ||
| Share repurchase | (17,787) | (18,255) |
| Proceeds from the exercise of common stock options | (339) | (123) |
| Borrowings on lines of credit | 18,664 | 16,636 |
Item 1. Financial Statements
FAQ
- What is Opko Health's investing cash flow?
- Opko Health (OPK) reported investing cash flow of $15.54M in Q2 2026.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Opko Health's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude